1. Home
  2. NLSP vs EVM Comparison

NLSP vs EVM Comparison

Compare NLSP & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • EVM
  • Stock Information
  • Founded
  • NLSP 2015
  • EVM 2002
  • Country
  • NLSP Switzerland
  • EVM United States
  • Employees
  • NLSP N/A
  • EVM N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • EVM Finance/Investors Services
  • Sector
  • NLSP Health Care
  • EVM Finance
  • Exchange
  • NLSP Nasdaq
  • EVM Nasdaq
  • Market Cap
  • NLSP 243.8M
  • EVM 236.6M
  • IPO Year
  • NLSP 2021
  • EVM N/A
  • Fundamental
  • Price
  • NLSP $4.90
  • EVM $9.55
  • Analyst Decision
  • NLSP
  • EVM
  • Analyst Count
  • NLSP 0
  • EVM 0
  • Target Price
  • NLSP N/A
  • EVM N/A
  • AVG Volume (30 Days)
  • NLSP 25.9K
  • EVM 55.8K
  • Earning Date
  • NLSP 10-11-2024
  • EVM 01-01-0001
  • Dividend Yield
  • NLSP N/A
  • EVM 4.01%
  • EPS Growth
  • NLSP N/A
  • EVM N/A
  • EPS
  • NLSP N/A
  • EVM 0.20
  • Revenue
  • NLSP N/A
  • EVM N/A
  • Revenue This Year
  • NLSP N/A
  • EVM N/A
  • Revenue Next Year
  • NLSP N/A
  • EVM N/A
  • P/E Ratio
  • NLSP N/A
  • EVM $47.61
  • Revenue Growth
  • NLSP N/A
  • EVM N/A
  • 52 Week Low
  • NLSP $4.08
  • EVM $7.67
  • 52 Week High
  • NLSP $40.60
  • EVM $9.59
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 37.46
  • EVM 42.06
  • Support Level
  • NLSP $4.72
  • EVM $9.54
  • Resistance Level
  • NLSP $5.50
  • EVM $9.67
  • Average True Range (ATR)
  • NLSP 0.65
  • EVM 0.07
  • MACD
  • NLSP 0.02
  • EVM -0.01
  • Stochastic Oscillator
  • NLSP 28.47
  • EVM 13.33

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value

Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.

Share on Social Networks: